ロード中...

The discovery and development of belimumab: the anti-BLyS–lupus connection

For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator...

詳細記述

保存先:
書誌詳細
主要な著者: Stohl, William, Hilbert, David M
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3264947/
https://ncbi.nlm.nih.gov/pubmed/22231104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.2076
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!